This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Biosion, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Zeyu Peng: Inventor in Biomedical Research
Introduction
Zeyu Peng is an inventor associated with Nanjing, China, and Biosion, Inc. His patent work concerns antibody-based approaches to treating cancer, infectious diseases, and inflammatory diseases.
Latest Patents
The supplied information lists one patent associated with Peng: “Monoclonal Antibodies Which Bind PD-1, Encoding Nucleotides Thereof and Method of Use Thereof to Treat Cancer, Infectious Disease and Inflammatory Disease.” The patent describes PD-1-binding monoclonal antibodies, the nucleotides that encode them, and their potential therapeutic uses. The listed patent count is 1 patent.
Career Highlights
Peng’s listed invention focuses on PD-1, an immune checkpoint target studied in biomedical research. The patent’s stated applications span cancer, infectious diseases, and inflammatory diseases.
Collaborations
The supplied information identifies Biosion, Inc. as Peng’s company and Mingjiu Chen as his coworker. These details indicate a professional connection, but do not specify the nature or extent of their collaboration.
Conclusion
Zeyu Peng’s listed patent reflects work on PD-1-targeting antibodies and their potential applications across several disease areas.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile